ACTUAL RATES ARE STILL LOW: Prolonged use of injectable contraceptive tied to brain tumor diagnoses. “Analyses showed that depot medroxyprogesterone acetate users had a 143% higher risk of meningioma diagnosis than matched controls, with incidence 7.39 per 100,000 patient-years in the injection cohort and 3.05 in controls.”

Interestingly, I noticed this at the end: “Written for you by our author Justin Jackson, edited by Sadie Harley, and fact-checked and reviewed by Robert Egan—this article is the result of careful human work.”

We’ve reached the point at which journalism is bragging about not being done by AI.